0/202 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches
2009 de Crevoisier R, Louvel G, Cazoulat G, Leseur J, Lafond C, Lahbabi K, Chira C, Lagrange JL. [Image-guided radiotherapy: rational, modalities and results]. Bulletin Du Cancer. 96: 123-32. PMID 19211367 DOI: 10.1684/bdc.2009.0801  0.01
2007 Lagrange JL, Guerif S. [T1-T2 prostate cancer: treatment by radiation therapy]. Bulletin Du Cancer. 94: F5-14. PMID 17845988 DOI: 10.1684/bdc.2007.0243  0.01
2012 Noel G, Huchet A, Feuvret L, Maire JP, Verrelle P, Le Rhun E, Aumont M, Thillays F, Sunyach MP, Henzen C, Missohou F, de Crevoisier R, Bondiau PY, Collin P, Durando X, ... ... Lagrange JL, et al. Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy. Journal of Neuro-Oncology. 109: 167-75. PMID 22660920 DOI: 10.1007/s11060-012-0883-7  0.01
2012 Fizazi K, Lesaunier F, Delva R, Gravis G, Rolland F, Priou F, Ferrero JM, Houedé N, Mourey L, Theodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, Fléchon A, ... ... Lagrange JL, et al. A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial. European Journal of Cancer (Oxford, England : 1990). 48: 209-17. PMID 22119204 DOI: 10.1016/j.ejca.2011.10.015  0.01
2012 Thariat J, Aluwini S, Pan Q, Caullery M, Marcy PY, Housset M, Lagrange JL. Image-guided radiation therapy for muscle-invasive bladder cancer. Nature Reviews. Urology. 9: 23-9. PMID 22064641 DOI: 10.1038/nrurol.2011.173  0.01
2011 Beckendorf V, Guerif S, Le Prisé E, Cosset JM, Bougnoux A, Chauvet B, Salem N, Chapet O, Bourdain S, Bachaud JM, Maingon P, Hannoun-Levi JM, Malissard L, Simon JM, Pommier P, ... ... Lagrange JL, et al. 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial. International Journal of Radiation Oncology, Biology, Physics. 80: 1056-63. PMID 21147514 DOI: 10.1016/j.ijrobp.2010.03.049  0.01
2011 Lagrange JL, Bascoul-Mollevi C, Geoffrois L, Beckendorf V, Ferrero JM, Joly F, Allouache N, Bachaud JM, Chevreau C, Kramar A, Chauvet B. Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015). International Journal of Radiation Oncology, Biology, Physics. 79: 172-8. PMID 20385453 DOI: 10.1016/j.ijrobp.2009.10.038  0.01
2006 de Crevoisier R, Lagrange JL, Messai T, M'Barek B, Lefkopoulos D. [Prostate localization systems for prostate radiotherapy]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 10: 394-401. PMID 17035061 DOI: 10.1016/j.canrad.2006.09.002  0.01
2003 Marcié S, Martin E, Bensadoun RJ, Magné N, Hérault J, Costa A, Hachem A, Lagrange JL. [Study of theoretical cases of intensity-modulated beams with step-and-shoot technique]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 7: 179-83. PMID 12834773  0.01
2003 Magné N, Porsin B, Marcy PY, Benezery K, Poudenx M, Vallino P, Otto J, Marcié S, Lagrange JL. [Reappraisal of the role of endobronchial brachytherapy in the management of lung cancer: ten years' experience at the centre Antoine-Lacassagne]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 7: 160-5. PMID 12834770 DOI: 10.1016/S1278-3218(03)00026-X  0.01
2000 Ruffié P, Lehmann M, Galateau-Sallé F, Lagrange JL, Pairon JC. [Standards, options and guidelines for management of patients with malignant mesothelioma of the pleura]. Presse MéDicale (Paris, France : 1983). 29: 1432-6. PMID 11036521  0.01
2016 Kempf E, Caillet P, Rousseau B, Le Thuaut A, Bastuji-Garin S, Liuu E, Lagrange JL, Tournigand C, Paillaud E, Canouï-Poitrine F. What Do Older Adults Know About Their Cancer Diagnosis and Treatment? The ELCAPA-08 Cohort Study. Journal of the American Geriatrics Society. 64: 1360-2. PMID 27321623 DOI: 10.1111/jgs.14154  0.01
2016 Dréan G, Acosta O, Ospina JD, Fargeas A, Lafond C, Corrégé G, Lagrange JL, Créhange G, Simon A, Haigron P, de Crevoisier R. Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27173457 DOI: 10.1016/j.radonc.2016.04.023  0.01
2016 Carrie C, Hasbini A, de Laroche G, Richaud P, Guerif S, Latorzeff I, Supiot S, Bosset M, Lagrange JL, Beckendorf V, Lesaunier F, Dubray B, Wagner JP, N'Guyen TD, Suchaud JP, et al. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. The Lancet. Oncology. PMID 27160475 DOI: 10.1016/S1470-2045(16)00111-X  0.01
2016 Viau M, Perez AF, Bodgi L, Devic C, Granzotto A, Ferlazzo ML, Bourguignon M, Puisieux A, Lacornerie T, Lartigau É, Lagrange JL, Foray N. [Repeated radiation dose effect and DNA repair: Importance of the individual factor and the time interval between the doses]. Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique. PMID 27020715 DOI: 10.1016/j.canrad.2015.05.035  0.01
2016 Ferrat E, Audureau E, Paillaud E, Liuu E, Tournigand C, Lagrange JL, Canoui-Poitrine F, Caillet P, Bastuji-Garin S. Four Distinct Health Profiles in Older Patients With Cancer: Latent Class Analysis of the Prospective ELCAPA Cohort. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 27006079 DOI: 10.1093/gerona/glw052  0.01
2016 Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, Bodgi L, Pereira S, Sonzogni L, Forcheron F, Viau M, Etaix A, Malek K, Mengue-Bindjeme L, Escoffier C, ... ... Lagrange JL, et al. Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity. International Journal of Radiation Oncology, Biology, Physics. 94: 450-60. PMID 26867874 DOI: 10.1016/j.ijrobp.2015.11.013  0.01
2015 Azria D, Riou O, Castan F, Nguyen TD, Peignaux K, Lemanski C, Lagrange JL, Kirova Y, Lartigau E, Belkacemi Y, Bourgier C, Rivera S, Noël G, Clippe S, Mornex F, et al. Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial. Ebiomedicine. 2: 1965-73. PMID 26844275 DOI: 10.1016/j.ebiom.2015.10.024  0.01
2015 Sargos P, Guerif S, Latorzeff I, Hennequin C, Pommier P, Lagrange JL, Créhange G, Chapet O, de Crevoisier R, Azria D, Supiot S, Habibian M, Soulié M, Richaud P. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU). Cancer Treatment Reviews. PMID 26508669 DOI: 10.1016/j.ctrv.2015.10.005  0.01
2015 Maazoun F, Gellen Dautremer J, Boutekadjirt A, Pissard S, Habibi A, Bachir D, Rahmouni A, Bartolucci P, Debbache K, Lagrange JL, Michel M, Galacteros F. [Symptomatic extramedullary haematopoiesis in β-thalassemia: A retrospective single centre study]. La Revue De Medecine Interne / Fondee ... Par La Societe Nationale Francaise De Medecine Interne. PMID 26410419 DOI: 10.1016/j.revmed.2015.07.005  0.01
2015 Thureau S, Leysalle A, Faivre JC, Lagrange JL. [Radiotherapy of bone metastases: Which fractionations?]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 19: 437-41. PMID 26321686 DOI: 10.1016/j.canrad.2015.06.015  0.01
2015 Canoui-Poitrine F, Reinald N, Laurent M, Guery E, Caillet P, David JP, Tournigand C, Lagrange JL, Bastuji-Garin S, Lemogne C, Paillaud E. Geriatric assessment findings independently associated with clinical depression in 1092 older patients with cancer: the ELCAPA Cohort Study. Psycho-Oncology. PMID 26123351 DOI: 10.1002/pon.3886  0.01
2015 Fizazi K, Faivre L, Lesaunier F, Delva R, Gravis G, Rolland F, Priou F, Ferrero JM, Houede N, Mourey L, Theodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, ... ... Lagrange JL, et al. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial. The Lancet. Oncology. PMID 26028518 DOI: 10.1016/S1470-2045(15)00011-X  0.01
2015 Ferrat E, Paillaud E, Laurent M, Le Thuaut A, Caillet P, Tournigand C, Lagrange JL, Canouï-Poitrine F, Bastuji-Garin S. Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 25834194 DOI: 10.1093/gerona/glv025  0.01
2015 Azria D, Riou O, Castan F, Nguyen TD, Peignaux K, Lemanski C, Lagrange JL, Kirova Y, Lartigau E, Belkacemi Y, Bourgier C, Rivera S, Noël G, Clippe S, Mornex F, et al. Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial Ebiomedicine. DOI: 10.1016/j.ebiom.2015.10.024  0.01
2015 Thureau S, Hanzen C, Dubray B, Lagrange JL. Radiotherapy for bones metastases: Current indications and new perspectives | Radiothérapie des métastases osseuses : indications actuelles et nouvelles perspectives Oncologie. 17: 91-95. DOI: 10.1007/s10269-015-2492-5  0.01
2014 Sbai A, Thariat J, Tachfouti N, Pan Q, Lagrange JL. [Intraprostatic calcifications as natural fiducial markers in image-guided radiotherapy for prostate cancer]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 18: 740-4. PMID 25451671 DOI: 10.1016/j.canrad.2014.07.161  0.01
2014 Caillet P, Laurent M, Bastuji-Garin S, Liuu E, Culine S, Lagrange JL, Canoui-Poitrine F, Paillaud E. Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment. Clinical Interventions in Aging. 9: 1645-60. PMID 25302022 DOI: 10.2147/CIA.S57849  0.01
2014 de Crevoisier R, Castelli J, Guérif S, Pommier P, Créhange G, Chauvet B, Lagrange JL. [Prostate cancer: what treatment techniques for which tumors? Ethical and methodological issues]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 18: 369-78. PMID 25199865 DOI: 10.1016/j.canrad.2014.07.154  0.01
2014 Guérif S, Latorzeff I, Lagrange JL, Hennequin C, Supiot S, Garcia A, François P, Soulié M, Richaud P, Salomon L. [Postoperative radiotherapy of prostate cancer]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 18: 517-23. PMID 25195116 DOI: 10.1016/j.canrad.2014.07.149  0.01
2014 Ospina JD, Zhu J, Chira C, Bossi A, Delobel JB, Beckendorf V, Dubray B, Lagrange JL, Correa JC, Simon A, Acosta O, de Crevoisier R. Random forests to predict rectal toxicity following prostate cancer radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 89: 1024-31. PMID 25035205 DOI: 10.1016/j.ijrobp.2014.04.027  0.01
2014 Cassier PA, Kantor G, Bonvalot S, Lavergne E, Stoeckle E, Le Péchoux C, Meeus P, Sunyach MP, Vaz G, Coindre JM, Linassier C, Labib A, Delcambre C, Bay JO, Leyvraz S, ... ... Lagrange JL, et al. Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 1854-60. PMID 24914041 DOI: 10.1093/annonc/mdu202  0.01
2014 Kunkler IH, Audisio R, Belkacemi Y, Betz M, Gore E, Hoffe S, Kirova Y, Koper P, Lagrange JL, Markouizou A, Pfeffer R, Villa S. Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 2134-46. PMID 24625455 DOI: 10.1093/annonc/mdu104  0.01
2014 Laurent M, Paillaud E, Tournigand C, Caillet P, Le Thuaut A, Lagrange JL, Beauchet O, Vincent H, Carvahlo-Verlinde M, Culine S, Bastuji-Garin S, Canouï-Poitrine F. Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study. The Oncologist. 19: 275-82. PMID 24569945 DOI: 10.1634/theoncologist.2013-0351  0.01
2014 Mathieu R, Arango JD, Beckendorf V, Delobel JB, Messai T, Chira C, Bossi A, Le Prisé E, Guerif S, Simon JM, Dubray B, Zhu J, Lagrange JL, Pommier P, Gnep K, et al. Nomograms to predict late urinary toxicity after prostate cancer radiotherapy. World Journal of Urology. 32: 743-51. PMID 23990073 DOI: 10.1007/s00345-013-1146-8  0.01
2014 Lagrange JL. Recherches sur la Méthode de maximis et minimis Traces and Emergence of Nonlinear Programming. 415-434. DOI: 10.1007/978-3-0348-0439-4_19  0.01
2013 Thariat J, Fric D, Kerr C, Leysalle A, Angellier G, Dejean C, Tuillier T, Bensadoun RJ, Lagrange JL. [Advances in radiation oncology for metastatic bone disease]. Bulletin Du Cancer. 100: 1187-97. PMID 24172705 DOI: 10.1684/bdc.2013.1849  0.01
2013 Leysalle A, Fric D, Lagrange JL, Thariat J. [Radiotherapy of bone metastases]. Bulletin Du Cancer. 100: 1175-85. PMID 24158700 DOI: 10.1684/bdc.2013.1845  0.01
2013 Régnier É, Nguyen TD, Beckendorf V, Lagrange JL. [Bladder cancer radiotherapy margins]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 17: 470-6. PMID 23969246 DOI: 10.1016/j.canrad.2013.06.024  0.01
2013 Chauvet B, Mahé MA, Maingon P, Mazeron JJ, Mornex F, Chauvet B, Mahé MA, Maingon P, Mazeron JJ, Mornex F, Azria D, Barillot I, Chauvet B, Denis F, ... ... Lagrange JL, et al. [White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 17: S2-72. PMID 23916854 DOI: 10.1016/j.canrad.2013.04.002  0.01
2013 Dennis K, Zhang L, Lutz S, van der Linden Y, van Baardwijk A, Holt T, Lagrange JL, Foro-Arnalot P, Wong LC, Maranzano E, Wong KH, Liu R, Vassiliou V, Corn BW, De Angelis C, et al. International radiation oncology trainee decision making in the management of radiotherapy-induced nausea and vomiting. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 2041-8. PMID 23440546 DOI: 10.1007/s00520-013-1759-x  0.01
2013 Perrier L, Morelle M, Pommier P, Lagrange JL, Laplanche A, Dudouet P, Supiot S, Chauvet B, Nguyen TD, Crehange G, Beckendorf V, Pene F, Muracciole X, Bachaud JM, Le Prisé E, et al. Cost of prostate image-guided radiation therapy: results of a randomized trial. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 106: 50-8. PMID 23333022 DOI: 10.1016/j.radonc.2012.11.011  0.01
2012 Pan Q, Calitchi E, Otmezguine Y, Feuilhade F, Le Bourgeois JP, Pierquin B, Lagrange JL. [Long-term results of exclusive radiotherapy and brachytherapy of breast cancer]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 16: 674-80. PMID 23103447 DOI: 10.1016/j.canrad.2012.07.187  0.01
2012 Pommier P, Morelle M, Perrier L, de Crevoisier R, Laplanche A, Dudouet P, Mahé MA, Chauvet B, Nguyen TD, Créhange G, Zawadi A, Chapet O, Latorzeff I, Bossi A, Beckendorf V, ... ... Lagrange JL, et al. [Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 16: 444-51. PMID 22951488 DOI: 10.1016/j.canrad.2012.07.178  0.01
2012 Thariat J, Leysalle A, Vignot S, Marcy PY, Lacout A, Bera G, Lagrange JL, Clezardin P, Chiras J. [Oligometastatic bone disease. Can limited metastatic bone disease be cured? Is there room for local ablative treatments?]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 16: 330-8. PMID 22921977 DOI: 10.1016/j.canrad.2012.05.016  0.01
2012 Dennis K, Zhang L, Lutz S, van Baardwijk A, van der Linden Y, Holt T, Arnalot PF, Lagrange JL, Maranzano E, Liu R, Wong KH, Wong LC, Vassiliou V, Corn BW, De Angelis C, et al. International patterns of practice in the management of radiation therapy-induced nausea and vomiting. International Journal of Radiation Oncology, Biology, Physics. 84: e49-60. PMID 22704982 DOI: 10.1016/j.ijrobp.2012.02.031  0.01
2012 Stivalet A, Luciani A, Pigneur F, Dao TH, Beaussart P, Merabet Z, Perlbarg J, Meyblum E, Baranes L, Calitchi E, Lepage C, Belkacemi Y, Lagrange JL, Lantieri L, Rahmouni A. Invasive lobular carcinoma of the breast: MRI pathological correlation following bilateral total mastectomy. Acta Radiologica (Stockholm, Sweden : 1987). 53: 367-75. PMID 22553225 DOI: 10.1258/ar.2012.110477  0.01
2012 Pan Q, Thariat J, Bogalhas F, Lagrange JL. [Assessment of movements of the different anatomic portions of the bladder, implications for image-guided radiation therapy for bladder cancer]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 16: 167-78. PMID 22365260 DOI: 10.1016/j.canrad.2011.10.015  0.01
2012 Thariat J, Italiano A, Collin F, Iannessi A, Marcy PY, Lacout A, Birtwisle-Peyrottes I, Thyss A, Lagrange JL. Not all sarcomas developed in irradiated tissue are necessarily radiation-induced--spectrum of disease and treatment characteristics. Critical Reviews in Oncology/Hematology. 83: 393-406. PMID 22138059 DOI: 10.1016/j.critrevonc.2011.11.004  0.01
2011 Ghadjar P, Kaanders JH, Poortmans P, Zaucha R, Krengli M, Lagrange JL, Özsoy O, Nguyen TD, Miralbell R, Baize A, Boujelbene N, Collen T, Scandolaro L, Untereiner M, Goldberg H, et al. The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network. International Journal of Radiation Oncology, Biology, Physics. 81: e583-91. PMID 21775069 DOI: 10.1016/j.ijrobp.2011.05.028  0.01
2011 Magné N, Chargari C, Mirimanoff RO, Olivier P, Vuillez JP, Tubiana-Hulin M, Body JJ, Lagrange JL. European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 19: 1565-72. PMID 20809195 DOI: 10.1007/s00520-010-0983-x  0.01
2011 Pommier P, Dussart S, Girinsky T, Chabaud S, Lagrange JL, Nguyen TD, Beckendorff V, D'Hombres A, Artignan X, Bondiau PY, Carrie C, Giammarile F. Impact of 18F-fluoro-2-deoxyglucose positron emission tomography on treatment strategy and radiotherapy planning for stage I-II Hodgkin disease: a prospective multicenter study. International Journal of Radiation Oncology, Biology, Physics. 79: 823-8. PMID 20452732 DOI: 10.1016/j.ijrobp.2009.11.048  0.01
2011 Rannou S, Guirimand N, Cartron L, Du Fraval FT, Sahbatou Y, Lagrange JL, Benoît G, Leplège A, Besson C. Experience of the communication of the diagnosis of cancer in the context of the French national guidelines | Le vécu de l'annonce d'un cancer à l'ère du dispositif d'annonce Psycho-Oncologie. 5: 227-234. DOI: 10.1007/s11839-011-0330-6  0.01
2010 Thariat J, Marcy PY, Lagrange JL. [Trends in radiation therapy for the treatment of metastatic and oligometastatic disease in 2010]. Bulletin Du Cancer. 97: 1467-76. PMID 21220224 DOI: 10.1684/bdc.2010.1230  0.01
2010 Lisbona A, Averbeck D, Supiot S, Delpon G, Ali D, Vinas F, Diana C, Murariu C, Lagrange JL. [IMRT combined to IGRT: increase of the irradiated volume. Consequences?]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 14: 563-70. PMID 20729117 DOI: 10.1016/j.canrad.2010.07.227  0.01
2010 Drouet F, Lagrange JL. [Normal tissue tolerance to external beam radiation therapy: bone marrow]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 14: 392-404. PMID 20598617 DOI: 10.1016/j.canrad.2010.04.006  0.01
2010 Lagrange JL, de Crevoisier R. [Image guided radiation therapy (IGRT)]. Bulletin Du Cancer. 97: 857-65. PMID 20581000 DOI: 10.1684/bdc.2010.1140  0.01
2010 Pouessel D, Thariat J, Lagrange JL, Mottet N, Culine S. [Perioperative strategies in patients with muscle invasive bladder cancer]. Bulletin Du Cancer. 97: 5-9. PMID 20534384 DOI: 10.1684/bdc.2010.1096  0.01
2009 Marinello G, Mege JP, Besse MC, Kerneur G, Lagrange JL. [Prostate radiation therapy: in vivo measurement of the dose delivered by kV-CBCT]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 13: 353-7. PMID 19640761 DOI: 10.1016/j.canrad.2009.05.012  0.01
2009 Thariat J, Caullery M, Ginot A, Hannoun-Lévi JM, Barrière J, Buthaud X, Marcié S, Bondiau PY, Housset M, Lagrange JL, Amiel J, Gérard JP. [State of the art and advances in radiotherapy for bladder cancer]. ProgrèS En Urologie : Journal De L'Association FrançAise D'Urologie Et De La SociéTé FrançAise D'Urologie. 19: 85-93. PMID 19168010 DOI: 10.1016/j.purol.2008.11.002  0.01
2009 Luciani A, Pigneur F, Ghozali F, Dao TH, Cunin P, Meyblum E, De Baecque-Fontaine C, Alamdari A, Maison P, Deux JF, Lagrange JL, Lantieri L, Rahmouni A. Ex vivo MRI of axillary lymph nodes in breast cancer. European Journal of Radiology. 69: 59-66. PMID 19112002 DOI: 10.1016/j.ejrad.2008.07.040  0.01
2009 Marinello G, Mege JP, Herve ML, Lagrange JL. In vivo measurements of the dose delivered by kilovoltage cone-beam CT during prostate radiation therapy Ifmbe Proceedings. 25: 356-357. DOI: 10.1007/978-3-642-03474-9-100  0.01
2009 Lagrange JL. Bone metastases and treatment by irradiation European Journal of Oncology Pharmacy. 3: 28-29.  0.01
2008 Azria D, Belkacemi Y, Lagrange JL, Chapet O, Mornex F, Maingon P, Hennequin C, Rosenstein B, Ozsahin M. [Radiation-induced sequelae: toward an individual profile]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 12: 619-24. PMID 18757226 DOI: 10.1016/j.canrad.2008.07.009  0.01
2008 Azria D, Auvray H, Barillot I, Baumann P, Benyoucef A, Bons-Rosset F, Bontemps P, Bourgier C, Breton-Callu C, Cowen D, Cretin J, Delalande B, Denis F, Ellis S, Gaci Z, ... ... Lagrange JL, et al. [Ductal carcinoma in situ: role of the boost]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 12: 571-6. PMID 18703372 DOI: 10.1016/j.canrad.2008.07.005  0.01
2008 Lagrange JL, Bourhis J. [What is the future of the children after therapeutic irradiation of their mother during their pregnancy?]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 12: 867-8. PMID 18676169 DOI: 10.1016/j.canrad.2008.06.005  0.01
2008 Lagrange JL, Pan C, Calitchi E, Diana C, Muresan M, Wu JF, El Monkles H, Wang XW, Lu H. Practical radiation therapy for painful bone metastases | Radiothérapie pratique des métastases osseuses symptomatiques Revue Du Rhumatisme (Edition Francaise). 75: 530-535. DOI: 10.1016/j.rhum.2008.02.005  0.01
2007 Pommier P, Chabaud S, Lagrange JL, Richaud P, Lesaunier F, Le Prise E, Wagner JP, Hay MH, Beckendorf V, Suchaud JP, Pabot du Chatelard PM, Bernier V, Voirin N, Perol D, Carrie C. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5366-73. PMID 18048817 DOI: 10.1200/JCO.2006.10.5171  0.01
2007 de Crevoisier R, Isambert A, Lisbona A, Bodez V, Marguet M, Lafay F, Remonnay R, Lagrange JL. [Image-guided radiotherapy]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 11: 296-304. PMID 17889585 DOI: 10.1016/j.canrad.2007.08.002  0.01
2007 Padovani L, Sunyach MP, Perol D, Mercier C, Alapetite C, Haie-Meder C, Hoffstetter S, Muracciole X, Kerr C, Wagner JP, Lagrange JL, Maire JP, Cowen D, Frappaz D, Carrie C. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. International Journal of Radiation Oncology, Biology, Physics. 68: 433-40. PMID 17498567 DOI: 10.1016/j.ijrobp.2006.12.030  0.01
2007 Pierquin B, Tubiana M, Pan C, Lagrange JL, Calitchi E, Otmezguine Y. Long-term results of breast cancer irradiation treatment with low-dose-rate external irradiation. International Journal of Radiation Oncology, Biology, Physics. 67: 117-21. PMID 17189067 DOI: 10.1016/j.ijrobp.2006.03.065  0.01
2007 Pommier P, Martin E, Lagrange JL, Beckendorf V. Radiotherapy for adenocarcinoma of the prostate | Radiothérapie des adénocarcinomes de la prostate Oncologie. 9: 487-493. DOI: 10.1007/s10269-007-0691-4  0.01
2006 Lagrange JL, Zelek L. [Limb and retroperitoneal sarcomas: progress with an optimal multidisciplinary management]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 10: 1-2. PMID 16442828 DOI: 10.1016/j.canrad.2005.10.014  0.01
2005 Jordana F, Lagrange JL, Gérard JP, Amiel J. [Role of the combination of external radiotherapy--partial cystectomy--interstitial brachytherapy in pT1 G3, pT2 and pT3 bladder tumors]. Annales D'Urologie. 39: S104-12. PMID 16425727  0.01
2005 Cordonnier C, Maury S, Esperou H, Pautas C, Beaune J, Rodet M, Lagrange JL, Rouard H, Beaumont JL, Bassompierre F, Glückman E, Kuentz M, Durand-Zaleski I. Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia. Bone Marrow Transplantation. 36: 649-54. PMID 16044135 DOI: 10.1038/sj.bmt.1705109  0.01
2005 Chretien F, Dreyfus PA, Christov C, Caramelle P, Lagrange JL, Chazaud B, Gherardi RK. In vivo fusion of circulating fluorescent cells with dystrophin-deficient myofibers results in extensive sarcoplasmic fluorescence expression but limited dystrophin sarcolemmal expression. The American Journal of Pathology. 166: 1741-8. PMID 15920159 DOI: 10.1016/S0002-9440(10)62484-4  0.01
2005 Ortholan C, Ramaioli A, Peiffert D, Lusinchi A, Romestaing P, Chauveinc L, Touboul E, Peignaux K, Bruna A, de La Roche G, Lagrange JL, Alzieu C, Gerard JP. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 62: 479-85. PMID 15890590 DOI: 10.1016/j.ijrobp.2004.09.060  0.01
2005 Claude L, Rousmans S, Carrie C, Breteau N, Dijoud F, Gentet JC, Giammarile F, Jouve JL, Kind M, Marec-Bérard P, Mascard E, Bataillard A, Philip T, Allavena C, Babin-Boilletot A, ... ... Lagrange JL, et al. Standards and Options for the use of radiation therapy in the management of patients with osteosarcoma. Update 2004 | Recommandations pour la pratique clinique: Standards, Options et Recommandations pour la prise en charge par radioth́rapie des patients atteints d'ost́osarcome. Mise à jour Cancer/Radiotherapie. 9: 174-191. PMID 15880886 DOI: 10.1016/j.canrad.2005.01.007  0.01
2005 Magné N, François E, Touati L, Marcy PY, Van Houtte P, Lagrange JL. [Role of an exclusive concomitant radio-chemotherapy treatment in non operable esophageal cancer: results of a 10-year experience in Antoine-Lacassagne Center]. Bulletin Du Cancer. 92: 184-90. PMID 15749648  0.01
2005 Guibout C, Adjadj E, Rubino C, Shamsaldin A, Grimaud E, Hawkins M, Mathieu MC, Oberlin O, Zucker JM, Panis X, Lagrange JL, Daly-Schveitzer N, Chavaudra J, de Vathaire F. Malignant breast tumors after radiotherapy for a first cancer during childhood. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 197-204. PMID 15625374 DOI: 10.1200/JCO.2005.06.225  0.01
2004 Beckendorf V, Guérif S, Le Prisé E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, et al. The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity. International Journal of Radiation Oncology, Biology, Physics. 60: 1056-65. PMID 15519775 DOI: 10.1016/j.ijrobp.2004.05.033  0.01
2004 Audet JF, Ruiz L, Sèbe P, Totobenazsara JL, Paule B, Lagrange JL, Abbou CC, de la Taille A. [Neoplasms induced by radiotherapy for prostate cancer: report of a case of pelvic sarcoma and review of the literature]. ProgrèS En Urologie : Journal De L'Association FrançAise D'Urologie Et De La SociéTé FrançAise D'Urologie. 14: 420-2. PMID 15373192  0.01
2004 Menu-Branthomme A, Rubino C, Shamsaldin A, Hawkins MM, Grimaud E, Dondon MG, Hardiman C, Vassal G, Campbell S, Panis X, Daly-Schveitzer N, Lagrange JL, Zucker JM, Chavaudra J, Hartman O, et al. Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. International Journal of Cancer. Journal International Du Cancer. 110: 87-93. PMID 15054872 DOI: 10.1002/ijc.20002  0.01
2003 Kirova Y, Locher C, Lagrange JL. Mediastinal irradiation in patients with esophageal carcinoma after heart transplantation. Cancer. 98: 2737-8. PMID 14669299 DOI: 10.1002/cncr.11896  0.01
2003 Villers A, Pommier P, Bataillard A, Fervers B, Bachaud JM, Berger N, Bertrand AF, Bouvier R, Brune D, Daver A, Fontaine E, Haillot O, Lagrange JL, Molinie V, Muratet JP, et al. Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001). British Journal of Cancer. 89: S50-8. PMID 12915903 DOI: 10.1038/sj.bjc.6601084  0.01
2003 Depierre A, Lagrange JL, Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Bréchot JM, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, et al. Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000). British Journal of Cancer. 89: S35-49. PMID 12915902 DOI: 10.1038/sj.bjc.6601083  0.01
2003 Salomon L, Porcher R, Anastasiadis AG, Levrel O, Saint F, De la Taille A, Vordos D, Cicco A, Hoznek A, Chopin D, Abbou CC, Lagrange JL. Introducing a prognostic score for pretherapeutic assessment of seminal vesicle invasion in patients with clinically localized prostate cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 67: 313-9. PMID 12865180 DOI: 10.1016/S0167-8140(03)00053-7  0.01
2003 Hoffstetter S, Marchal C, Bordigoni P, Girinsky T, Martel-Lafay I, Belkacémi Y, Lebourgeois JP, Richaud P, Mahé MA, Alzieu C, Pons A, Cosset JM, Prévost B, Urbajtel M, Bolla M, ... ... Lagrange JL, et al. Total body irradiation in France in the past twenty years | Irradiation corporelle totale en France au cours des 20 dernières années Cancer/Radiotherapie. 7: 166-171. PMID 12834771 DOI: 10.1016/S1278-3218(03)00005-2  0.01
2003 Martin E, Hachem A, Marcié S, Hérault J, Costa A, Bensadoun RJ, Lagrange JL. Validation of intensity modulation on a commercial treatment planning system. Medical Physics. 30: 925-36. PMID 12773002 DOI: 10.1118/1.1568981  0.01
2003 Magné N, Fischel JL, Formento P, Etienne MC, Dubreuil A, Marcié S, Lagrange JL, Milano G. Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status. Oncology. 64: 280-7. PMID 12697970 DOI: 10.1159/000069308  0.01
2003 Depierre A, Lagrange JL, Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Bréchot JM, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, et al. [Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients]. Bulletin Du Cancer. 90: 151-66. PMID 12660134  0.01
2003 Marcié S, Martin E, Bensadoun RJ, Magné N, Hérault J, Costa A, Hachem A, Lagrange JL. Study of theoretical cases of intensity-modulated beams with step-and-shoot technique | Étude de cas théoriques de faisceaux avec modulation d'intensité par la technique du step-and-shoot Cancer/Radiotherapie. 7: 179-183. DOI: 10.1016/S1278-3218(03)00025-8  0.01
2003 Villers A, Pommier P, Bataillard A, Fervers B, Bachaud JM, Berger N, Bertrand AF, Bouvier R, Brune D, Daver A, Fontaine E, Haillot O, Lagrange JL, Molinié V, Muratet JP, et al. Summary of the standards, options and recommendations for the management of patients with non-metastatic prostate cancer (2001) Electronic Journal of Oncology. 101-114.  0.01
2003 Depierre A, Lagrange JL, Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Bréchot JM, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, et al. Summary report of the standards, options and recommendations for the management of patients with non-small cell lung carcinoma (2000) Electronic Journal of Oncology. 83-100.  0.01
2002 Beckendorf V, Bachaud JM, Bey P, Bourdin S, Carrie C, Chapet O, Cowen D, Guérif S, Hay HM, Lagrange JL, Maingon P, Le Prisé E, Pommier P, Simon JM. [Target-volume and critical-organ delineation for conformal radiotherapy of prostate cancer: experience of French dose-escalation trials]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 6: 78s-92s. PMID 12587386  0.01
2002 Bréchot JM, Molina T, Theobald S, Depierre A, Lagrange JL, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, et al. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer]. Bulletin Du Cancer. 89: 857-67. PMID 12441277  0.01
2002 Magné N, Benezery K, Otto J, Namer M, Lagrange JL. [Radiation recall dermatitis after docetaxel and external beam radiotherapy. Report of two cases and review of the literature]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 6: 281-4. PMID 12412364 DOI: 10.1016/S1278-3218(02)00202-0  0.01
2002 Villers A, Pabot Du Chatelard P, Pommier P, Soulié M, Bataillard A, Fervers B, Bachaud JM, Berger N, Bertrand AF, Bouvier R, Brune D, Daver A, Fontaine E, Hajllot O, Lagrange JL, et al. Standards, Options and Recommendations for the management of prostate cancer: Therapeutic decision criteria | Standards, Options et Recommandations 2001 pour la prise en charge des patients atteints de cancer de la prostate non métastatique: Éléments de la décision thérapeutique Bulletin Du Cancer. 89: 619-634. PMID 12135863  0.01
2002 Pommier P, Villers A, Bataillard A, Brune D, Fervers B, Bachaud JM, Berger N, Bertrand AF, Bouvier R, Daver A, Fontaine E, Haillot O, Lagrange JL, Molinié V, Muratet JP, et al. [Standards, options, and recommendation for external radiotherapy of prostatic cancer: evaluation of the effect of dosage]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 6: 119-26. PMID 12035484 DOI: 10.1016/S1278-3218(02)00152-X  0.01
2002 Magné N, Fischel JL, Dubreuil A, Formento P, Marcié S, Lagrange JL, Milano G. Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer. British Journal of Cancer. 86: 819-27. PMID 11875748 DOI: 10.1038/sj.bjc.6600103  0.01
2001 Pommier P, Villers A, Bataillard A, Brune D, Fervers B, Bachaud JM, Berger N, Bertrand AF, Bouvier R, Daver A, Fontaine E, Guilloneau B, Haillot O, Lagrange JL, Molinié V, et al. [Standards, Options, and Recommendations for brachytherapy in patients with prostate cancer: efficacy and toxicity]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 5: 770-86. PMID 11797299 DOI: 10.1016/S1278-3218(01)00138-X  0.01
2001 Lagrange JL, Lipinski F. [The place of conformal radiotherapy in routine practice: national survey of SFRO members]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 5: 44s-48s. PMID 11797284  0.01
2001 Cattan N, Rochet N, Mazeau C, Zanghellini E, Mari B, Chauzy C, Stora de Novion H, Amiel J, Lagrange JL, Rossi B, Gioanni J. Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors. British Journal of Cancer. 85: 1412-7. PMID 11720483 DOI: 10.1054/bjoc.2001.2105  0.01
2001 Lagrange JL, Kirova Y, Le Bourgeois JP, Cosset JM. [Hodgkin's disease: from gross tumor volume to clinical target volume, firm data and unresolved problems]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 5: 650-8. PMID 11715316 DOI: 10.1016/S1278-3218(01)00105-6  0.01
2001 Lagrange JL, Ramaioli A, Theodore CH, Terrier-Lacombe MJ, Beckendorf V, Biron P, Chevreau CH, Chinet-Charrot P, Dumont J, Delobel-Deroide A, D'Anjou J, Chassagne C, Parache RM, Karsenty JM, Mercier J, et al. Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 12: 1313-9. PMID 11697846 DOI: 10.1023/A:1012224123385  0.01
2001 Touboul E, Lagrange JL, Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Bréchot J, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Le Chevalier T, Lemarie E, et al. [Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 5: 452-63. PMID 11521393 DOI: 10.1016/S1278-3218(01)00116-0  0.01
2001 Magné N, Pivot X, Marcy PY, Chauvel P, Courdi A, Dassonville O, Poissonnet G, Vallicioni J, Ettore F, Falewee MN, Milano G, Santini J, Lagrange JL, Schneider M, Demard F, et al. [Concomitant bifractionated radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in locally progressive, non-resectable epidermoid carcinomas of the pharynx: ten years experience at the Antoine Lacassagne center]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 5: 413-24. PMID 11521390 DOI: 10.1016/S1278-3218(01)00112-3  0.01
2001 Magné N, Marcié S, Pignol JP, Casagrande F, Lagrange JL. Radiotherapy for a solitary brain metastasis during pregnancy: a method for reducing fetal dose. The British Journal of Radiology. 74: 638-41. PMID 11509400 DOI: 10.1259/bjr.74.883.740638  0.01
2001 Beckendorf V, Pommier P, Carrie C, Bey P, Cowen D, Gonzague-Casabianca L, Maingon P, Horiot JC, Lagrange JL, Madelis G, Luporsi E. [Multicenter study on dose escalation with conformal and conventional radiotherapy for the treatment of localized prostatic cancer. Preliminary results of tolerance and quality of life]. ProgrèS En Urologie : Journal De L'Association FrançAise D'Urologie Et De La SociéTé FrançAise D'Urologie. 11: 264-76. PMID 11400488  0.01
2001 Bardet E, Moro-Sibilot D, Le Chevalier T, Massard G, Douillard JY, Theobald S, Astoul P, Baldeyrou P, Bazelly B, Bréchot J, Breton JL, Grivaux P, Jacoulet P, Khalil A, Lemarie E, ... ... Lagrange JL, et al. [Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma]. Bulletin Du Cancer. 88: 369-87. PMID 11371371  0.01
2001 Ruffié P, Lehmann M, Galateau-Sallé F, Lagrange JL, Pairon JC. Malignant mesothelioma. British Journal of Cancer. 84: 49-50. PMID 11355969 DOI: 10.1054/bjoc.2001.1763  0.01
2001 Ruffié P, Lehmann M, Galateau-Sallé F, Lagrange JL, Pairon JC. SOR malignant mesothelioma Electronic Journal of Oncology. 43-45.  0.01
2000 Hassen-Khodja R, Sala F, Declemy S, Lagrange JL, Bouillane PJ, Batt M. Surgical management of atherosclerotic carotid artery stenosis after cervical radiation therapy. Annals of Vascular Surgery. 14: 608-11. PMID 11128455 DOI: 10.1007/s100169910110  0.01
2000 Bey P, Carrie C, Beckendorf V, Ginestet C, Aletti P, Madelis G, Luporsi E, Pommier P, Cowen D, Gonzague-Casabianca L, Simonian-Sauve M, Maingon P, Naudy S, Lagrange J, Marcie S. Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results. International Journal of Radiation Oncology, Biology, Physics. 48: 513-7. PMID 10974470 DOI: 10.1016/S0360-3016(00)00691-X  0.01
2000 Lagrange JL, Ramaioli A, Chateau MC, Marchal C, Resbeut M, Richaud P, Lagarde P, Rambert P, Tortechaux J, Seng SH, de la Fontan B, Reme-Saumon M, Bof J, Ghnassia JP, Coindre JM. Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Fédération Nationale des Centres de Lutte Contre le Cancer. Radiology. 216: 197-205. PMID 10887248 DOI: 10.1148/radiology.216.1.r00jl02197  0.01
2000 Pivot X, Marghali N, Etienne MC, Bensadoun RJ, Thyss A, Otto J, François E, Renée N, Lagrange JL, Schneider M, Milano G. A multivariate analysis for predicting cisplatin-induced delayed emesis. Oncology Reports. 7: 515-9. PMID 10767361  0.01
1999 de Vathaire F, Hardiman C, Shamsaldin A, Campbell S, Grimaud E, Hawkins M, Raquin M, Oberlin O, Diallo I, Zucker JM, Panis X, Lagrange JL, Daly-Schveitzer N, Lemerle J, Chavaudra J, et al. Thyroid carcinomas after irradiation for a first cancer during childhood. Archives of Internal Medicine. 159: 2713-9. PMID 10597762 DOI: 10.1001/archinte.159.22.2713  0.01
1999 Carrie C, Hoffstetter S, Gomez F, Moncho V, Doz F, Alapetite C, Murraciole X, Maire JP, Benhassel M, Chapet S, Quetin P, Kolodie H, Lagrange JL, Cuillere JC, Habrand JL. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP). International Journal of Radiation Oncology, Biology, Physics. 45: 435-9. PMID 10487567 DOI: 10.1016/S0360-3016(99)00200-X  0.01
1999 Dautzenberg B, Arriagada R, Chammard AB, Jarema A, Mezzetti M, Mattson K, Lagrange JL, Le Pechoux C, Lebeau B, Chastang C. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer. 86: 265-73. PMID 10421262 DOI: 10.1002/(SICI)1097-0142(19990715)86:2<265::AID-CNCR10>3.0.CO;2-B  0.01
1999 Legros L, Benezery K, Lagrange JL. [Radiotherapy in primary cerebral lymphoma]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 3: 149-53. PMID 10230374 DOI: 10.1016/S1278-3218(99)80045-6  0.01
1999 Marchal C, Weber B, de Lafontan B, Resbeut M, Mignotte H, du Chatelard PP, Cutuli B, Reme-Saumon M, Broussier-Leroux A, Chaplain G, Lesaunier F, Dilhuydy JM, Lagrange JL. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers. International Journal of Radiation Oncology, Biology, Physics. 44: 113-9. PMID 10219803 DOI: 10.1016/S0360-3016(98)00537-9  0.01
1999 de Vathaire F, Hawkins M, Campbell S, Oberlin O, Raquin MA, Schlienger JY, Shamsaldin A, Diallo I, Bell J, Grimaud E, Hardiman C, Lagrange JL, Daly-Schveitzer N, Panis X, Zucker JM, et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. British Journal of Cancer. 79: 1884-93. PMID 10206309 DOI: 10.1038/sj.bjc.6690300  0.01
1999 Lagrange JL, Beckendorf V. Radiation therapy techniques for localized carcinoma of the prostate | Techniques de radiotherapie des cancers localises de la prostate Oncologie. 1: 396-401.  0.01
1998 Bensadoun RJ, Etienne MC, Dassonville O, Chauvel P, Pivot X, Marcy PY, Prevost B, Coche-Dequeant B, Bourdin S, Vallicioni J, Poissonnet G, Courdi A, Teissier E, Lagrange JL, Thyss A, et al. Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study. International Journal of Radiation Oncology, Biology, Physics. 42: 237-45. PMID 9788400 DOI: 10.1016/S0360-3016(98)00235-1  0.01
1998 Rozan R, Albuisson E, Giraud B, Boiteux JP, Dauplat J, Donnarieix D, Alcaraz L, Auvray H, Allain YM, Pabot Duchatelard P, Pigneux J, Richaud P, Bonichon F, Bachaud JM, Hay M, ... ... Lagrange JL, et al. External beam radiation of stage T1-T2 M0 adenocarcinoma of the prostate. An analysis of 610 patients treated in a multicenter survey (complications excluded) | Radiotherapie de l'adenocarcinome prostatique de stade T1-T2 M0. Analyse des resultats carcinologiques d'une etude multicentrique de 610 patients Cancer/Radiotherapie. 2: 338-350. PMID 9755747 DOI: 10.1016/S1278-3218(98)80345-4  0.01
1998 Ruffié P, Lehmann M, Galateau-Sallé F, Lagrange JL, Pairon JC. [Standards, Options, and Recommendations for the management of patients with malignant mesothelioma of the pleura. Fédération Nationale des Centres de Lutte Contre le Cancer]. Bulletin Du Cancer. 85: 545-61. PMID 9752282  0.01
1998 Le Vu B, de Vathaire F, Shamsaldin A, Hawkins MM, Grimaud E, Hardiman C, Diallo I, Vassal G, Bessa E, Campbell S, Panis X, Daly-Schveitzer N, Lagrange JL, Zucker JM, Eschwège F, et al. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. International Journal of Cancer. Journal International Du Cancer. 77: 370-7. PMID 9663598 DOI: 10.1002/(SICI)1097-0215(19980729)77:3<370::AID-IJC11>3.0.CO;2-C  0.01
1998 Lagrange JL, Colomban P. Double particle reinforcement of ceramic-matrix composites prepared by a sol-gel route Composites Science and Technology. 58: 653-658.  0.01
1997 Lagrange JL. Late effects of irradiation on bladder | Effets tardifs de l'irradiation sur la vessie Cancer/Radiotherapie. 1: 764-769. PMID 9614892 DOI: 10.1016/S1278-3218(97)82954-X  0.01
1997 Lagrange JL, Médecin B, Etienne MC, Pivot X, Cassuto-Viguier E, Renée N, Thyss A, Ferrero JM, Otto J, François E, Milano G. Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors. Pharmacotherapy. 17: 1246-53. PMID 9399607  0.01
1997 Lebrun C, Chanalet S, Paquis P, Frenay M, Lagrange JL, Chatel M. Solitary meningeal plasmacytomas. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 8: 791-5. PMID 9332688 DOI: 10.1023/A:1008288020194  0.01
1997 Pujol JL, Douillard JY, Rivière A, Quoix E, Lagrange JL, Berthaud P, Bardonnet-Comte M, Polin V, Gautier V, Milleron B, Chomy F, Chomy P, Spaeth D, Le Chevalier T. Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: A multicenter randomized phase III study Journal of Clinical Oncology. 15: 2082-2089. PMID 9164221  0.01
1997 Lagrange M, Ferrero JM, Lagrange JL, Machiavello JC, Monticelli J, Bayle C, Creisson A, Namer M, Thyss A, Bourcier C, Gioanni J, Schneider M. Non-specifically labelled cells that simulate bone marrow metastases inpatients with non-metastatic breast cancer Journal of Clinical Pathology. 50: 206-211. PMID 9155670  0.01
1997 Beckendort V, Lagrange JL, Hay M, Rozan R, N'Guyen T. Radical radiation therapy for the cancer of the prostate: A two-year evaluation of digestive, urinary and sexual functions. A survey of the tumor study group of the french federation of cancer centers British Journal of Urology. 80: 261.  0.01
1997 Blouet E, Lagrange JL, Verger L, Le Borgne G. Prise en compte du procede de mise en forme d'un brancard dans les parametres materiaux de simulation au CRASH Journal De Physique. Iv : Jp. 7: 945-950.  0.01
1997 Richelme C, Monpoux F, Sirvent N, Lonjon M, Lagrange JL, Roche JL, Michiels JF, Mariani R. Intracranial ependymoma in pediatric patients. A review of six cases | Ependymomes intracraniens de l'enfant. A propos d'une serie personnelle de six cas Annales De Pediatrie. 44: 238-244.  0.01
1996 Lagrange JL, Bondiau PY, Tessier E, Chauvel P, Renée N, Etienne MC, Milano G. Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer International Journal of Cancer. 68: 452-456. PMID 8945615 DOI: 10.1002/(SICI)1097-0215(19961115)68:4<452::AID-IJC9>3.0.CO;2-#  0.01
1996 Gioanni J, Zanghellini E, Mazeau C, Amiel J, Poustis-Delpont C, Lagrange JL, Duplay H, Caldani C, Courdi A. CAL 54, a new cell line derived from a human renal carcinoma: Characterization and radiosensitivity | CAL 54, une nouvelle lignee cellulaire derivee d'un carcinome renal humain: Caracterisation et radiosensibilite Bulletin Du Cancer. 83: 553-558. PMID 8868943  0.01
1996 Tchiknavorian X, Otto J, Lagrange JL, Thyss A. Esophageal bezoars: late complication of mediastinal radiotherapy | Bézoard oesophagien: complication tardive d'une radiothérapie médiastinale Presse MéDicale (Paris, France : 1983). 25: 951. PMID 8685161  0.01
1996 Beckendorf V, Hay M, Rozan R, Lagrange JL, Guyen T, Giraud B. Changes in sexual function after radiotherapy treatment of prostate cancer British Journal of Urology. 77: 118-123. PMID 8653281  0.01
1996 Colomban P, Bruneton E, Lagrange JL, Mouchon E. Sol-gel Mullite Matrix-SiC and -Mullite 2D Woven Fabric Composites with or without Zirconia Containing Interphase: Elaboration and Properties Journal of the European Ceramic Society. 16: 301-314. DOI: 10.1016/0955-2219(95)00189-1  0.01
1995 Serge M, Costa A, Lagrange JL. Protection of testes during radiation treatment by irregular and focused fields of 25 MV X-rays: in vivo evaluation of the absorbed dose Medical Dosimetry. 20: 269-273. PMID 8703322 DOI: 10.1016/0958-3947(95)02003-9  0.01
1995 Etienne MC, Lagrange JL, Francois E, Renée N, Bajard F, Milano G. Portable pumps in cancer chemotherapy: How to deal with marked fluctuations in 5-Fluorouracil blood concentrations European Journal of Cancer. 31: 2414-2415. PMID 8652279 DOI: 10.1016/0959-8049(95)00414-9  0.01
1995 Etienne MC, Milano G, Renée N, Lagrange JL, Dassonville O, Thyss A, Schneider M, François E, Fleming R, Demard F. A population study of dihydropyrimidine dehydrogenase in cancer patients | Etude de population de la dihydropyrimidine déshydrogénase chez des sujets cancéreux Bulletin Du Cancer. 82: 705-710. PMID 8535028 DOI: 10.1016/0007-4551(96)80000-2  0.01
1995 Keita O, Lagrange JL, Michiels JF, Soler C, Garcia J, Valla - JS, Thyss A. Primary bronchogenic squamous cell carcinoma in children: Report of a case and review of the literature Medical and Pediatric Oncology. 24: 50-52. PMID 7968793 DOI: 10.1002/mpo.2950240111  0.01
1995 Cowen D, Richaud P, Mornex F, Bachelot T, Jung GM, Mirabel X, Marchal C, Lagrange JL, Rambert P, Chaplain G. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 34: 9-16. PMID 7792406 DOI: 10.1016/0167-8140(94)01493-M  0.01
1995 Mornex F, Resbeut M, Richaud P, Jung GM, Mirabel X, Marchal C, Lagrange JL, Rambert P, Chaplain G, Nguyen TD. Radiotherapy and chemotherapy for invasive thymomas: A multicentric retrospective review of 90 cases International Journal of Radiation Oncology, Biology, Physics. 32: 651-659. PMID 7790251 DOI: 10.1016/0360-3016(95)00079-E  0.01
1995 Lagrange JL, Maublant J, Darcourt J. Positron emission tomography: role of 18F-fluorodeoxyglucose (18FDG) imaging in oncology | Tomographie par émission de positons: place de l'exploration par 18F-fluorodéoxyglucose (18FDG) en oncologie Bulletin Du Cancer. 82: 611-622. PMID 7492817 DOI: 10.1016/0007-4551(96)80876-9  0.01
1995 Lagrange JL, Milano G, Schneider M. 1er Séminaire de thérapie génique des cancers du centre Antoine-Lacassagne Bulletin Du Cancer. 82: 218.  0.01
1995 Maublant J, Lagrange JL. Applications of fluor-18-fluoro-2-deoxyglucose in oncology | APPLICATIONS DU FLUOR-18-FLUORO-2-DESOXYGLUCOSE EN CANCEROLOGIE Medecine Nucleaire. 19: 64-72.  0.01
1994 Moro D, Jacoulet P, Quoix E, Ranfaing E, Brambilla E, Capron F, Lagrange JL, Milleron B, Lebeau B, Ruffie P, Riviere A, Blanchon F, Geraads A, Depierre A. Small cell lung cancer: Patients surviving longer than thirty months Anticancer Research. 14: 301-304. PMID 8166471  0.01
1994 Lacour JP, Castanet J, Lagrange JL, Ortonne JP. Follicular mycosis fungoides: Response to radiation therapy [1] British Journal of Dermatology. 130: 256-257. PMID 8123581 DOI: 10.1111/j.1365-2133.1994.tb02911.x  0.01
1994 Bondiau PY, Peyrade F, Creisson A, Pivot X, Lagrange JL, Thyss A. Severe hypocalcemia after treatment with diphosphonates and aminoglycosides [2] | HYPOCALCEMIE SEVERE APRES TRAITEMENT PAR DIPHOSPHONATES ET AMINOGLYCOSIDES [2] Presse Medicale. 23: 816. PMID 8078844  0.01
1994 Bondiau PY, Pivot X, Peyrade F, Lagrange JL, Santini J, Hofman P, Thyss A. Primary adenocarcinoma of the lacrimal glands. A case | Adénocarcinome primitif des glandes lacrymales. Une observation Presse Medicale (Paris, France : 1983). 23: 671. PMID 8072967  0.01
1994 Etienne MC, Lagrange JL, Dassonville O, Fleming R, Thyss A, Renée N, Schneider M, Demard F, Milano G. Population study of dihydropyrimidine dehydrogenase in cancer patients Journal of Clinical Oncology. 12: 2248-2253. PMID 7964939  0.01
1994 Carrie C, Lasset C, Alapetite C, Haie-Meder C, Hoffstetter S, Demaille - MC, Kerr C, Wagner JP, Lagrange JL, Maire JP, Seng SH, Yo Oye Chong Tao Kong Man, Murraciole X, Pinto N. Multivariate analysis of prognostic factors in adult patients with medulloblastoma: Retrospective study of 156 patients Cancer. 74: 2352-2360. PMID 7922986 DOI: 10.1002/1097-0142(19941015)74:8<2352::AID-CNCR2820740821>3.0.CO;2-H  0.01
1994 Lagrange JL, Cassuto-Viguier E, Barbé V, Fischel JL, Mondain JR, Etienne MC, Ferréro JM, Creisson-Ducray A, Formento P, Milano G. Cytotoxic effects of long-term circulating ultrafiltrable platinum species and limited efficacy of haemodialysis in clearing them European Journal of Cancer. 30: 2057-2060. PMID 7857703 DOI: 10.1016/0959-8049(94)00332-Y  0.01
1994 Rostagno P, Moll JL, Birtwisle-Peyrottes I, Ettore F, Lagrange JL, Gioanni J, Caldani C. Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling Anticancer Research. 14: 2025-2032. PMID 7531416  0.01
1994 Lagrange JL, Noel A. Role of in vivo dosimetry in radiotherapy | PLACE DE LA DOSIMETRIE IN VIVO EN RADIOTHERAPIE Bulletin Du Cancer/Radiotherapie. 81: 456-462.  0.01
1994 Costa A, Lagrange JL, Marcie S. Practice of silicon diodes detectors for quality control in external radiation therapy | PRATIQUE DES DETECTEURS A SEMI-CONDUCTEURS POUR LE CONTROLE DES TRAITEMENTS EN RADIOTHERAPIE EXTERNE Bulletin Du Cancer/Radiotherapie. 81: 465-466.  0.01
1993 Ferrari E, Lagrange JL, Taillan B, Baudouy M, Morand P. Cardiac complications of radiotherapy | Complications cardiaques de la radiothérapie Annales De Medecine Interne. 144: 23-27. PMID 8503602  0.01
1993 Etienne MC, Milano G, Lagrange JL, Bajard F, François E, Thyss A, Schneider M, Renée N, Fety R. Marked fluctuations in drug plasma concentrations caused by use of portable pumps for fluorouracil continuous infusion Journal of the National Cancer Institute. 85: 1005-1007. PMID 8496975 DOI: 10.1093/jnci/85.12.1005  0.01
1993 Pesce A, Filippi C, Rosenthal E, Taillan B, Garnier G, Vinti H, Gratecos N, Poitou G, Garbe L, Michiels JF, Lagrange JL, Cassuto JP. Malignant fibrous histiocytoma following bone marrow transplantation for acute leukemia Transplantation Proceedings. 25: 2299-2301. PMID 8390741  0.01
1993 Lagrange JL, Fischel JL, Galliani S, Formento P, Guillot T, Bardon M, Milano G. Importance of the irradiation timing within a chemoradiotherapy sequence including cisplatin and 5-FU-folinic acid. Experimental results European Journal of Cancer. 29: 1531-1535. PMID 8217357 DOI: 10.1016/0959-8049(93)90289-R  0.01
1993 Lagrange JL, Francoual M, Formento JL, Del Guidice P, Bensadoun RJ, Teissier E, Ettore F, Gillet JY, Namer M, Milano G. Demonstration and characterization of EGF receptors in cancer of the uterine cervix | Mise en évidence et caractérisation des récepteurs d'EGF dans les cancers du col de l'utérus Bulletin Du Cancer. 80: 219-224. PMID 8173174  0.01
1993 Peyrade F, Bondiau PY, Peroux JL, Hofman P, Lagrange JL, Thyss A. Rectal Hodgkin's disease in a patient with HIV infection | Maladie de Hodgkin rectale chez un patient infecté par le VIH Presse Medicale (Paris, France : 1983). 22: 1883. PMID 8115339  0.01
1993 Haie-Meder C, Pellae-Cosset B, Laplanche A, Lagrange JL, Tuchais C, Nogues C, Arriagada R. Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases Radiotherapy and Oncology. 26: 111-116. PMID 7681997 DOI: 10.1016/0167-8140(93)90091-L  0.01
1993 Pesce A, Rosenthal E, Taillan B, Garnier G, Vinti H, Gratecos N, Lagrange JL, Dujardin P, Cassuto JP. Histiocytome fibreux malin après allogreffe de moelle pour leucémie aiguë La Revue De Medecine Interne. 14: 580.  0.01
1993 Pesce A, Rosenthal E, Taillan B, Barnier G, Vinti H, Gratecos N, Lagrange JL, Dujardin P, Cassuto JP. Malignant histocytoma after bone marrow transplantation in acute leukemia | HISTIOCYTOME FIBREUX MALIN APRES ALLOGREFFE DE MOELLE POUR LEUCEMIE AIGUE Revue De Medecine Interne. 14: 580.  0.01
1992 Lagrange M, Gaspard MH, Lagrange JL, Michiels JF, Hofman P, Thyss A, Schneider M. Granulocytic sarcoma with meningeal leukemia but no bone marrow involvement at presentation: A report of two cases with characteristic cerebrospinal fluid cytology Acta Cytologica. 36: 319-324. PMID 1580114  0.01
1992 Lagrange JL, Darcourt J, Benoliel J, Bensadoun RJ, Migneco O. Acute cardiac effects of mediastinal irradiation: Assessment by radionuclide angiography International Journal of Radiation Oncology, Biology, Physics. 22: 897-903. PMID 1555982 DOI: 10.1016/0360-3016(92)90785-G  0.01
1992 Lagrange JL, Courdi A, Chauvel P, Gioanni J, Ettore F, Bongain A, Duforestel T, Gillet JY. The labelling index in carcinoma of the uterine cervix: Its correlation with tumour sterilization British Journal of Radiology. 65: 63-65. PMID 1486370  0.01
1992 Albuisson E, Allain YM, Rozan R, Giraud B, Bolla M, Brune D, Carteaux A, Castelain B, Cuillere JC, Douchez J, Geslin J, Hay M, Jung E, Koechlin M, Lagrange JL, et al. Prostate cancer treated by radiotherapy: a multivariate study Radiotherapy and Oncology. 25: 89-96. PMID 1438940 DOI: 10.1016/0167-8140(92)90014-L  0.01
1992 Carrie C, Alapetite C, Mere P, Aimard L, Pons A, Kolodie H, Seng S, Lagrange JL, Pontvert D, Pignon T, Lacroze M, Ginestet C, Bernard JL. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: The contribution of radiotherapy technique to tumour relapse Radiotherapy and Oncology. 24: 77-81. PMID 1323134 DOI: 10.1016/0167-8140(92)90282-Y  0.01
1992 Darcourt J, Lagrange JL, He ZX, Bensadoun RJ, Benoliel J, Migneco O, Bussiere-Lapalus F. Early effect of mediastinal irradiation on left ventricular function | EFFECT PRECOCE DE L'IRRADIATION MEDIASTINALE SUR LA FONCTION VENTRICULAIRE GAUCHE Journal De Medecine Nucleaire Et Biophysique. 16: 120-124.  0.01
1992 Chauvel P, Lagrange JL, Bensadoun RJ, Dupuy P, Marcy J, Geoffray A. Uterine perforation during utero-vaginal applications [1] | PERFORATION UTERINE AU COURS DE APPLICATIONS UTERO-VAGINALES Bulletin Du Cancer/Radiotherapie. 79: 167-168.  0.01
1991 Malissard L, Nguyen TD, Jung GM, Forward JJ, Castelain B, Tuchais C, Allain YM, Denepoux R, Lagrange JL, Panis X, Rathelot P, Chaplain G, Koechlin M, Rozan R. Localized adenocarcinoma of the lung: A retrospective study of 186 non-metastatic patients from the french federation of cancer institutes-the radiotherapy cooperative group International Journal of Radiation Oncology, Biology, Physics. 21: 369-373. PMID 2061113 DOI: 10.1016/0360-3016(91)90784-2  0.01
1991 Fontana X, Lagrange JL, Francois E, Bourry J, Chauvel P, Sordage M, Lapalus F, Namer M. Assessment of "squamous cell carcinoma antigen" (SCC) as a marker of epidermoid carcinoma of the anal canal Diseases of the Colon & Rectum. 34: 126-131. PMID 1993409 DOI: 10.1007/BF02049985  0.01
1991 Francois E, Lagrange JL, Benchimol D, Hebuterne X, Montoya ML, Fratini G, Rampal P, Richelme H, Namer M. Advanced cancers of the exocrine pancreas treated by a long-acting luteinising hormone releasing hormone (LHRH) analogue: Phase II study | CANCERS DU PANCREAS EXOCRINE EVOLUES TRAITES PAR UN ANALOGUE RETARD DE LA LUTEINISING HORMONE REALISING HORMONE (LH-RH) LA TRIPTORELINE: ETUDE DE PHASE II Annales De Chirurgie. 45: 909-911. PMID 1838237  0.01
1991 Fontana X, Lagrange JL, Francois E, Bourry J, Chauvel P, Sordage M, Lapalus F, Namer M. EvaluatiOn of 'squamous cell carcinoma antigen' as a marker of squamous carcinoma of the anal canal | EVALUATION DU 'SQUAMOUS CELL CARCINOMA ANTIGEN' COMME MARQUEUR DU CANCER EPIDERMOIDE DU CANAL ANAL Annales De Gastroenterologie Et D'Hepatologie. 27: 293-296. PMID 1772243  0.01
1991 Lagrange JL, Benchimol D, Francois E, Peroni JL, Mouroux J, Monticelli J, Richelme H. Role of radiotherapy in the treatment of locoregional recurrences of carcinomas of the rectum | PLACE DE LA RADIOTHERAPIE DANS LE TRAITEMENT DES RECIDIVES LOCO-REGIONALES DES CANCERS DU RECTUM Medecine Et Chirurgie Digestives. 20: 433-439.  0.01
1991 Darcourt J, Lagrange JL, He ZX, Benoliel J, Migneco O, Lapalus F. Early and asymptomatic response of left ventricular function during radiotherapy of the mediastinum | ATTEINTE PRECOCE ET ASYMPTOMATIQUE DE LA FONCTION VENTRICULAIRE GAUCHE AU COURS DE LA RADIOTHERAPIE MEDIASTINALE Journal De Medecine Nucleaire Et Biophysique. 15: 322.  0.01
1990 Bourry J, Lagrange JL, Chauvel P, Francois E, Abbes M, Monticelli J. Canal anal treatment by radiochemotherapy association: A report of 12 cases | TRAITEMENT DES CANCERS DU CANAL ANAL PAR ASSOCIATION RADIO-CHIMIOTHERAPIE: A PROPOS DE 12 CAS Bulletin Du Cancer. 77: 117-121. PMID 2317581  0.01
1990 Lagrange JL, Frenay M, Darcourt J, Francois E, Hery M, Namer M, Lapalus F. Is systemic bone scan useful for patients with operable breast cancer? | FAUT-IL FAIRE DES SCINTIGRAPHIES OSSEUSES SYSTEMATIQUES CHEZ LES PATIENTES PORTEUSES DE CANCER DU SEIN DE PETITE TAILLE? Journal De Gynecologie Obstetrique Et Biologie De La Reproduction. 19: 701-708. PMID 2258588  0.01
1990 Altschuler C, Resbeut M, Blaise D, Maraninchi D, Stoppa AM, Lagrange JL, Guillet JP, Carcassonne Y. Fractionated total body irradiation and bone marrow transplantation in acute lymphoblastic leukemia International Journal of Radiation Oncology, Biology, Physics. 19: 1151-1154. PMID 2254105 DOI: 10.1016/0360-3016(90)90220-E  0.01
1990 Milano G, Troger V, Courdi A, Fontana X, Chauvel P, Lagrange JL. Pharmacokinetics of cisplatin given at a daily low dose as a radiosensitiser Cancer Chemotherapy and Pharmacology. 27: 55-59. PMID 2245493 DOI: 10.1007/BF00689277  0.01
1990 Lagrange JL, Chauvel P, François E, Bourry J, Benchimol D, Bereder JM, Machiavello JC, Richelme H. Conservative treatment of epidermoid cancer of the anal canal combining radiotherapy and curietherapy. Experience at the Antoine-Lacassagne Center | Traitement conservateur du cancer épidermoïde du canal anal par association de radiothérapie et de curiethérapie. Expérience du Centre Antoine-Lacassagne Annales De Gastroenterologie Et D'Hepatologie. 26: 45-49. PMID 2189353  0.01
1990 Santini J, Serra C, Thyss A, Camuzard JF, Dassonville O, Lagrange JL, Favot C, Demard F. Malignant maxillofacial non-Hodgkin's lymphoma. Apropos of 15 cases involving the naso-sinus cavities | Lymphomes malins non hodgkiniens maxillo-faciaux. A propos de 15 localisations aux cavités naso-sinusiennes Revue De Stomatologie Et De Chirurgie Maxillo-Faciale. 91: 28-32. PMID 2130452  0.01
1989 Aiem A, Lagrange JL, Hery M. Effects of radiotherapy on the course of cerebral metastases: Role of CT | EFFETS DE LA RADIOTHERAPIE SUR L'EVOLUTION DES METASTASES CEREBRALES: APPORT DE LA TDM Annales De Radiologie. 32: 213-216. PMID 2782835  0.01
1989 Riviere A, Abouz D, Ayela P, Berthaud P, Frenay M, Lagrange JL, Pujol JL, Robillard J, Le Chevalier T. Phase II trial of CDDP and 5-FU in epidermoid and undifferentiated lung cancers | RESULTATS D'UNE ETUDE DE PHASE II D'UNE ASSOCIATION DE CIS-PLATINUM ET DE 5-FU DANS LES CANCERS BRONCHIQUES EPIDERMOIDES OU INDEFFERENCIES A GRANDES CELLULES Bulletin Du Cancer. 76: 1095-1102. PMID 2561418  0.01
1989 Lagrange JL, Aiem A, Bruneton JN. Brain metastases: Evaluation of response to treatment. Comparison of clinical and radiological responses | METASTASES CEREBRALES: EVALUATION DE LA REPONSE AU TRAITEMENT. COMPARAISON DES RESPONSES CLINIQUE ET RADIOLOGIQUE Semaine Des Hopitaux. 65: 2763-2766.  0.01
1989 Lagrange JL, Namer M, Frenay M, Verschoore J, Boublil JL. Combined radiotherapy and chemotherapy: toxicity of low dose adriamycin with irradiation of the lungs | ASSOCIATION RADIO-CHIMIOTHERAPIE. TOXICITE DE L'ADRIAMYCINE A FAIBLES DOSES ET DE L'IRRADIATION PULMONAIRE Semaine Des Hopitaux. 65: 1349-1351.  0.01
1988 Lagrange JL, Hoch M, Courdi A, Darcourt J, Benoiel J, Namer M, Hery M, Abbes M, Monticelli J, Schneider M, Lapalus F, Lalanne CM. Breast cancer: The value of bone scanning at diagnosis and for follow-up of patients with early breast cancer (T ≤ 3 cm) Bulletin Du Cancer. 75: 271-280. PMID 3370323  0.01
1988 Viens P, Lagrange JL, Thyss A, Ayela P, Frenay M, Schneider M. Brain metastases of lung cancer: Excessive toxicity of high dose VP 16 213 European Journal of Cancer and Clinical Oncology. 24: 1905-1906. PMID 3220088 DOI: 10.1016/0277-5379(88)90107-1  0.01
1988 Bruneton JN, Normand F, Lagrange JL, Balu-Maestro C, Ettore F, Padovani B, Rogopoulos A. Radical surgery for colorectal cancer. Follow up surveillance by CT scan imaging Journal De Radiologie. 69: 501-507. PMID 3057183  0.01
1988 Lagrange JL, Thyss A, Caldani C, Hery M, Schneider M, Bensadoun JR. Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement Bulletin Du Cancer. 75: 801-806. PMID 2460169  0.01
1988 Lagrange JL, Vinti H, Abbou C. Intrarenal metastases. Report of two cases of renal tumoral syndrome | METASTASES INTRA-RENALES. A PROPOS DE DEUX CAS DE SYNDROME TUMORAL DU REIN Semaine Des Hopitaux. 64: 3103-3106.  0.01
1988 Abbes M, Lagrange JL, Frenay M, Ettore F. Report of forty-five cases of recurrence after conservative treatment for breast cancer | A PROPOS DE QUARANTE-CINQ RECIDIVES APRES TRAITEMENT CONSERVATEUR POUR CANCER DU SEIN Semaine Des Hopitaux. 64: 1293-1297.  0.01
1987 Verschoore J, Lagrange JL, Boublil JL, Aubanel JM, Blaive B, Pinto J, Namer M. Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer Radiotherapy and Oncology. 9: 281-288. PMID 3685450 DOI: 10.1016/S0167-8140(87)80149-4  0.01
1987 Lagrange JL, Hoch M, Courdi A, benoliel J, Lapalus F, Namer M, Hery M, Lalanne CM, Schneider M. [Role of bone scintigraphy in small tumors of the breast (T less than 2-3 cm). Preliminary results]. Annales De MéDecine Interne. 138: 379-80. PMID 3674616  0.01
1987 Quintens H, Amiel J, Namer M, Raymond G, Toubol J, Lagrange JL. Bilateral successive germinal testicular tumors. Apropos of a case | Les tumeurs testiculaires germinales bilatérales et sucessives. A propos d'un cas Journal D'Urologie. 93: 580-581. PMID 3443776  0.01
1987 Lagrange JL, Thyss A, Caldani C, Schneider M, Hery M, Bourgeon A, Lebas P. Deep vein thrombosis of the upper limbs, an unusual complication of the treatment of lymphomas | THROMBOSE VEINEUSE DES MEMBRES SUPERIEURS, UNE COMPLICATION RARE DU TRAITEMENT DES LYMPHOMES Semaine Des Hopitaux. 63: 3513-3515.  0.01
Hide low-probability matches.